You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab

Article metrics

Article menu

Download PDFPDF

XML
Research Article
A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019110
Jan 2020880
Feb 202017179
Mar 2020292916
Apr 2020202030
May 2020181815
Jun 2020313139
Jul 2020242419
Aug 2020232316
Sep 2020414120
Oct 202040409
Nov 2020272714
Dec 2020232318
Jan 2021262515
Feb 202122227
Mar 2021373714
Apr 2021141411
May 2021282828
Jun 202135357
Jul 2021333322
Aug 2021181814
Sep 2021272712
Oct 2021252534
Nov 2021363630
Dec 2021303214
Jan 2022313312
Feb 2022283221
Mar 2022343630
Apr 2022414512
May 2022424622
Jun 2022434521
Jul 2022535622
Aug 202254544
Sep 2022464813
Oct 2022363614
Nov 2022444623
Dec 2022404013
Jan 2023525218
Feb 2023484813
Mar 2023313311
Apr 2023313213
May 2023181816
Jun 202330309
Jul 2023181923
Aug 2023141511
Sep 202317179
Oct 2023323212
Nov 2023232314
Dec 2023272713
Jan 2024545523
Feb 2024313114
Mar 2024313121
Apr 2024343513
May 2024313218
Jun 2024404019
Jul 2024343516
Aug 202412126
Sep 2024262614
Oct 2024383822
Nov 2024232413
Dec 2024293019
Jan 2025343542
Feb 202510810824
Mar 2025373724
Apr 2025535321
May 2025424224
Jun 2025282821
Feb 2026110
Total215221901136